GP78-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of GP78-1 monoclonal antibodies for research applications. GP78-1 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GP78, also known as AMFR, is an E3 ubiquitin ligase that plays a critical role in the endoplasmic reticulum-associated degradation (ERAD) pathway, facilitating the removal of misfolded proteins from the endoplasmic reticulum. Its function is essential for maintaining cellular homeostasis and regulating protein quality control, making GP78-1 a significant target in studies related to various diseases, including cancer and neurodegenerative disorders. Understanding GP78's role in cellular processes can provide insights into therapeutic strategies and disease mechanisms. GP78-1 monoclonal antibodies enable researchers to investigate protein regulation pathways with precision and reliability. Studying GP78-1 helps advance our knowledge of cellular quality control mechanisms and their implications in disease development. Research utilizing GP78-1 monoclonal antibodies contributes to expanding our understanding of protein degradation pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific discoveries and developing potential therapeutic approaches.